NASDAQ:ACHC - Acadia Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $81.89
  • Forecasted Upside: -0.87 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
▲ +1.2 (1.47%)

This chart shows the closing price for ACHC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Acadia Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACHC

Analyst Price Target is $81.89
▼ -0.87% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Acadia Healthcare in the last 3 months. The average price target is $81.89, with a high forecast of $95.00 and a low forecast of $69.00. The average price target represents a -0.87% upside from the last price of $82.61.

This chart shows the closing price for ACHC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Acadia Healthcare. This rating has held steady since October 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 1 sell ratings
  • 1 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 1 sell ratings
  • 1 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/1/2022Deutsche Bank AktiengesellschaftBoost Price Target$70.00 ➝ $82.00Low
7/28/2022UBS GroupBoost Price TargetBuy$82.00 ➝ $90.00Low
7/28/2022Jefferies Financial GroupBoost Price Target$85.00 ➝ $95.00Low
6/20/2022UBS GroupSet Price Target$82.00Low
6/16/2022Loop CapitalInitiated CoverageHold$72.00Medium
5/6/2022BMO Capital MarketsBoost Price Target$67.00 ➝ $82.00Low
5/4/2022MizuhoBoost Price Target$64.00 ➝ $69.00High
4/8/2022SVB LeerinkBoost Price TargetOutperform$80.00 ➝ $90.00High
3/2/2022Credit Suisse GroupBoost Price TargetOutperform$74.00 ➝ $78.00Medium
3/1/2022SVB LeerinkLower Price TargetOutperform$83.00 ➝ $80.00High
11/1/2021Credit Suisse GroupBoost Price TargetOutperform$68.00 ➝ $69.00Medium
9/27/2021SVB LeerinkInitiated CoverageOutperform$85.00Low
9/23/2021UBS GroupInitiated CoverageBuy$81.00Low
9/20/2021Credit Suisse GroupUpgradeNeutral ➝ Outperform$68.00High
9/9/2021CowenInitiated CoverageOutperform$79.00Medium
8/12/2021BarclaysInitiated CoverageUnderweight$69.00Low
8/4/2021Credit Suisse GroupBoost Price TargetNeutral$60.00 ➝ $68.00Medium
8/4/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$62.00 ➝ $70.00Medium
8/4/2021CitigroupBoost Price TargetBuy$73.00 ➝ $77.00Medium
7/9/2021Seaport Res PtnReiterated RatingNeutralHigh
5/3/2021CitigroupBoost Price Target$65.00 ➝ $73.00Low
5/3/2021Credit Suisse GroupBoost Price TargetNeutral$56.00 ➝ $60.00Medium
5/3/2021Raymond JamesBoost Price TargetStrong-Buy$65.00 ➝ $70.00High
4/30/2021MizuhoBoost Price TargetNeutral$53.00 ➝ $62.00Medium
4/19/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$55.00 ➝ $62.00High
3/1/2021Credit Suisse GroupBoost Price TargetNeutral$54.00 ➝ $56.00N/A
3/1/2021Raymond JamesBoost Price TargetStrong-Buy$48.00 ➝ $65.00Low
3/1/2021MizuhoBoost Price TargetNeutral$50.00 ➝ $53.00Low
12/31/2020Robert W. BairdReiterated RatingNeutralN/A
12/31/2020Credit Suisse GroupBoost Price Target$36.00 ➝ $44.00N/A
12/30/2020Jefferies Financial GroupBoost Price TargetSell ➝ Buy$44.00 ➝ $60.00N/A
12/18/2020MizuhoBoost Price TargetNeutral$35.00 ➝ $50.00High
11/17/2020UBS GroupUpgradeNeutral ➝ Buy$37.00 ➝ $54.00Medium
11/2/2020StephensBoost Price TargetPositive ➝ Equal Weight$33.00 ➝ $42.00Medium
11/2/2020Credit Suisse GroupBoost Price TargetNeutral$32.00 ➝ $36.00Low
11/2/2020MizuhoBoost Price TargetBuy$31.00 ➝ $35.00Low
11/2/2020Royal Bank of CanadaBoost Price TargetOutperform$37.00 ➝ $42.00Low
9/30/2020Raymond JamesUpgradeOutperform ➝ Strong-Buy$40.00 ➝ $48.00Low
9/11/2020Raymond JamesReiterated RatingBuyLow
8/6/2020Credit Suisse GroupBoost Price TargetNeutral$28.00 ➝ $32.00Low
8/6/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$28.00 ➝ $32.00Low
8/6/2020MizuhoBoost Price TargetNeutral$26.00 ➝ $31.00Low
5/7/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$32.00 ➝ $28.00Medium
5/6/2020Robert W. BairdLower Price TargetNeutral$36.00 ➝ $30.00High
5/6/2020Credit Suisse GroupLower Price TargetNeutral$33.00 ➝ $28.00High
5/6/2020MizuhoBoost Price TargetNeutral$24.00 ➝ $26.00High
5/6/2020Raymond JamesLower Price TargetOutperform$40.00 ➝ $35.00High
5/5/2020Wells Fargo & CompanyReiterated RatingHoldHigh
1/28/2020StephensInitiated CoverageEqual Weight$36.00Low
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$27.00Low
12/11/2019Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$37.00 ➝ $35.00Medium
10/10/2019Jefferies Financial GroupSet Price TargetBuy$40.00Low
9/20/2019UBS GroupBoost Price TargetNeutral$29.00 ➝ $34.00Medium
9/6/2019UBS GroupLower Price TargetNeutral$30.00 ➝ $29.00N/A
7/31/2019Raymond JamesDowngradeStrong-Buy ➝ Outperform$45.00High
5/31/2019MizuhoSet Price TargetHold$30.00Medium
5/2/2019Deutsche Bank AktiengesellschaftSet Price TargetHold$32.00Low
5/1/2019BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$33.00 ➝ $36.00High
3/4/2019Robert W. BairdLower Price TargetNeutral ➝ Neutral$40.00 ➝ $38.00Low
3/4/2019CitigroupLower Price TargetBuy ➝ Buy$43.00 ➝ $38.00Low
1/25/2019MizuhoSet Price TargetHold$30.00Low
1/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$27.00Medium
11/26/2018Jefferies Financial GroupReiterated RatingBuy$42.00Low
11/16/2018Cantor FitzgeraldReiterated RatingHold$39.00High
11/15/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$39.00High
11/14/2018CitigroupLower Price TargetBuy ➝ Buy$46.00 ➝ $43.00Low
10/18/2018MizuhoSet Price TargetHold$37.00Low
10/18/2018Cantor FitzgeraldReiterated RatingHold$39.00Medium
10/17/2018Craig HallumDowngradeBuy ➝ HoldLow
8/28/2018MizuhoSet Price TargetHold$37.00Low
8/1/2018BMO Capital MarketsDowngradeOutperform ➝ Market Perform$45.00Medium
7/31/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$44.00 ➝ $47.00High
7/31/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$40.00 ➝ $44.00High
2/27/2018Royal Bank of CanadaReiterated RatingBuy$45.00Low
2/25/2018Cantor FitzgeraldUpgradeNeutral ➝ OverweightLow
2/23/2018BMO Capital MarketsReiterated RatingOutperform ➝ Outperform$40.00 ➝ $45.00Low
2/22/2018Robert W. BairdSet Price TargetNeutral ➝ Hold$37.00 ➝ $42.00High
2/22/2018Credit Suisse GroupReiterated RatingNeutral ➝ Neutral$35.00 ➝ $40.00High
1/30/2018Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$41.00Low
12/19/2017Jefferies Financial GroupSet Price TargetBuy$42.00Medium
12/15/2017Robert W. BairdReiterated RatingHold$37.00Medium
11/2/2017Credit Suisse GroupInitiated CoverageNeutral ➝ Neutral$35.00N/A
10/30/2017MizuhoReiterated RatingBuy ➝ NeutralN/A
10/29/2017MizuhoDowngradeBuy ➝ Neutral$36.00N/A
10/26/2017BMO Capital MarketsLower Price TargetOutperform$52.00 ➝ $48.00N/A
10/26/2017Craig HallumReiterated RatingBuy$65.00 ➝ $41.00N/A
10/25/2017Jefferies Financial GroupSet Price TargetBuy$42.00N/A
10/25/2017CitigroupLower Price TargetBuy$61.00 ➝ $44.00N/A
10/25/2017Bank of AmericaLower Price TargetBuy$60.00 ➝ $52.00N/A
10/25/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$60.00 ➝ $37.00N/A
10/25/2017Robert W. BairdDowngradeOutperform ➝ Neutral$55.00 ➝ $38.00N/A
10/24/2017MizuhoSet Price TargetBuy$60.00N/A
10/24/2017Cantor FitzgeraldLower Price TargetNeutral$48.00 ➝ $39.00N/A
10/20/2017KeyCorpReiterated RatingBuy$59.00N/A
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$52.00N/A
10/11/2017Jefferies Financial GroupSet Price TargetBuy$60.00N/A
(Data available from 8/12/2017 forward)

News Sentiment Rating

0.43 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 1 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 2 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
  • 6 very positive mentions
  • 24 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Current Sentiment

  • 6 very positive mentions
  • 24 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Acadia Healthcare logo
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or 24-hour observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and offer therapeutic placement for children and adolescents with emotional disorders. As of February 28, 2022, it operated a network of 228 behavioral healthcare facilities with approximately 10,500 beds. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Read More

Today's Range

Now: $82.61
Low: $81.25
High: $82.66

50 Day Range

MA: $73.79
Low: $63.69
High: $82.91

52 Week Range

Now: $82.61
Low: $50.07
High: $83.63


484,127 shs

Average Volume

576,227 shs

Market Capitalization

$7.50 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Acadia Healthcare?

The following equities research analysts have issued reports on Acadia Healthcare in the last year: Barclays PLC, BMO Capital Markets, Cowen Inc, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., Loop Capital, Mizuho,, SVB Leerink LLC, TheStreet, and UBS Group AG.
View the latest analyst ratings for ACHC.

What is the current price target for Acadia Healthcare?

9 Wall Street analysts have set twelve-month price targets for Acadia Healthcare in the last year. Their average twelve-month price target is $81.89, suggesting a possible downside of 0.9%. Jefferies Financial Group Inc. has the highest price target set, predicting ACHC will reach $95.00 in the next twelve months. Mizuho has the lowest price target set, forecasting a price of $69.00 for Acadia Healthcare in the next year.
View the latest price targets for ACHC.

What is the current consensus analyst rating for Acadia Healthcare?

Acadia Healthcare currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ACHC will outperform the market and that investors should add to their positions of Acadia Healthcare.
View the latest ratings for ACHC.

What other companies compete with Acadia Healthcare?

How do I contact Acadia Healthcare's investor relations team?

Acadia Healthcare's physical mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The company's listed phone number is (615) 861-6000. The official website for Acadia Healthcare is Learn More about contacing Acadia Healthcare investor relations.